. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Breast Neoplasms/immunologyBreast Neoplasms/prevention & controlCD4-Positive T-Lymphocytes/immunologyCancer VaccinesDisease-Free SurvivalFemaleHumansReceptor, ErbB-2/immunology
Substances: See more » AE37 vaccineCancer VaccinesERBB2 protein, humanReceptor, ErbB-2
Year: 2012 PMID: 22426363 DOI: 10.4161/hv.19658
Source DB: PubMed Journal: Hum Vaccin Immunother ISSN: 2164-5515 Impact factor: 3.452